Penn Medicine Penn Neuromuscular Symposium 2025

• Target Audience: neurologists, physiatrists, and allied health professionals
• Sample video: contact me for sample video
• Information:

The annual Penn Neuromuscular Symposium will discuss available and novel therapies for patients with neuromuscular disorders ranging from immuno-modulation to gene therapy. Experts will also present clinical cases selected from the Penn neuromuscular clinic to discuss where new diagnostic methods and treatments apply. The course will be interactive and attendees are encouraged to participate and exchange their experience and ask questions as they see fit. The Symposium will also explain how to enhance collaboration and knowledge exchange among neurologists and other healthcare professionals taking care of this unique patient population, which will also help facilitate enrollment in exciting clinical trials.

Target Audience

Specialties – NEUROLOGICAL SURGERY, NEUROLOGY, NEUROLOGY WITH SPECIAL QUALIFICATION IN CHILD NEUROLOGY, PSYCHIATRY AND NEUROLOGY – Addiction Psychiatry, PSYCHIATRY AND NEUROLOGY – Brain Injury Medicine, PSYCHIATRY AND NEUROLOGY – Child and Adolescent Psychiatry, PSYCHIATRY AND NEUROLOGY – Clinical Neurophysiology, PSYCHIATRY AND NEUROLOGY – Consultation-Liaison Psychiatry, PSYCHIATRY AND NEUROLOGY – Epilepsy, PSYCHIATRY AND NEUROLOGY – Forensic Psychiatry, PSYCHIATRY AND NEUROLOGY – Geriatric Psychiatry, PSYCHIATRY AND NEUROLOGY – Hospice and Palliative Medicine, PSYCHIATRY AND NEUROLOGY – Neurodevelopmental Disabilities, PSYCHIATRY AND NEUROLOGY – Neuromuscular Medicine, PSYCHIATRY AND NEUROLOGY – Pain Medicine, PSYCHIATRY AND NEUROLOGY – Sleep Medicine, PSYCHIATRY AND NEUROLOGY – Vascular Neurology

Professions – Nurse Practitioners, Physicians

Learning Objectives

After completing this activity, participants should be able to:

Describe novel treatment in myasthenia gravis

Discuss new methods to diagnose and treat neuropathy in Hereditary Transthyretin Amyloidosis.

Discuss different type of demyelinating neuropathies and how to manage them

Describe novel treatments for people with SMA and ALS

Discuss management of neuromuscular complications of vasculitis

Apply antibody testing in inflammatory myopathies and describe novel therapies for inflammatory myopathies

Discuss gene therapy for hereditary myopathies

Discuss application of car-T in autoimmune neuromuscular disorders

The Penn Neuromuscular Symposium 2025 is best for neurologists, physiatrists, and allied health professionals managing patients with neuromuscular disorders. It’s ideal for:

Exploring novel therapies including immunomodulation and gene therapy

Engaging in interactive discussions on diagnostics and treatment strategies

• Topics:

Saturday, May 17, 2025

MORNING SESSION

AFTERNOON SESSION